Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

Benzer Materyaller

• Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
  Yazar:: Jazayeri-Tehrani, Seyed Ali, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
  Yazar:: Daneshi-Maskooni, Milad, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
  Yazar:: Daneshi-Maskooni, Milad, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
  Yazar:: Daneshi-Maskooni, Milad, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Oral nano‐curcumin on gingival inflammation in patients with gingivitis and mild periodontitis
  Yazar:: Malekzadeh, Meisam, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)